Healthcare provider profile · identity verified

Keith Kurose, MD

Family Practice · POMONA, CA · NPI 1881769339

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	459	168
Losartan Potassium	Losartan Potassium	374	119
Amlodipine Besylate	Amlodipine Besylate	340	126
Rosuvastatin Calcium	Rosuvastatin Calcium	273	95
Levothyroxine Sodium	Levothyroxine Sodium	261	95
Ozempic	Semaglutide	224	31
Metformin Hcl	Metformin Hcl	212	70
Metformin Hcl Er	Metformin Hcl	178	63
Lisinopril	Lisinopril	172	69
Pantoprazole Sodium	Pantoprazole Sodium	168	47
Potassium Chloride	Potassium Chloride	167	56
Simvastatin	Simvastatin	156	55
Albuterol Sulfate Hfa	Albuterol Sulfate	146	66
Glipizide	Glipizide	135	45
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	128	29
Pradaxa	Dabigatran Etexilate Mesylate	126	30
Metoprolol Tartrate	Metoprolol Tartrate	121	44
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	121	19
Tamsulosin Hcl	Tamsulosin Hcl	121	40
Alendronate Sodium	Alendronate Sodium	115	37
Omeprazole	Omeprazole	113	43
Hydrochlorothiazide	Hydrochlorothiazide	111	40
Meloxicam	Meloxicam	111	46
Gabapentin	Gabapentin	101	37
Furosemide	Furosemide	100	43
Acetaminophen-Codeine	Acetaminophen With Codeine	95	20
Atenolol	Atenolol	94	39
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	90	39
Lorazepam	Lorazepam	81	17
Sertraline Hcl	Sertraline Hcl	81	34
Terazosin Hcl	Terazosin Hcl	80	24
Trazodone Hcl	Trazodone Hcl	67	28
Hydralazine Hcl	Hydralazine Hcl	65	23
Allopurinol	Allopurinol	63	24
Tramadol Hcl	Tramadol Hcl	62	15
Humulin N	Insulin Nph Human Isophane	61	23
Oxycodone Hcl	Oxycodone Hcl	61	suppressed
Spironolactone	Spironolactone	61	22
Carvedilol	Carvedilol	60	21
Ibuprofen	Ibuprofen	58	29
Pregabalin	Pregabalin	58	15
Fluoxetine Hcl	Fluoxetine Hcl	56	16
Finasteride	Finasteride	52	16
Jardiance	Empagliflozin	49	18
Lactulose	Lactulose	45	17
Triamcinolone Acetonide	Triamcinolone Acetonide	44	33
Duloxetine Hcl	Duloxetine Hcl	43	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	41	16
Clopidogrel	Clopidogrel Bisulfate	39	14
Pravastatin Sodium	Pravastatin Sodium	37	11
Prednisone	Prednisone	37	31
Hydroxyzine Hcl	Hydroxyzine Hcl	36	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	35	15
Wixela Inhub	Fluticasone Propion/Salmeterol	35	14
Zolpidem Tartrate	Zolpidem Tartrate	35	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	34	34
Memantine Hcl	Memantine Hcl	34	11
Cephalexin	Cephalexin	33	27
Famotidine	Famotidine	33	13
Alvesco	Ciclesonide	31	14
Propranolol Hcl	Propranolol Hcl	31	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	30	19
Donepezil Hcl	Donepezil Hcl	29	suppressed
Estradiol	Estradiol	29	14
Warfarin Sodium	Warfarin Sodium	29	13
Acyclovir	Acyclovir	28	12
Nortriptyline Hcl	Nortriptyline Hcl	28	suppressed
Ondansetron Odt	Ondansetron	28	16
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Mirtazapine	Mirtazapine	27	11
Alprazolam	Alprazolam	26	suppressed
Buspirone Hcl	Buspirone Hcl	26	suppressed
Fenofibrate	Fenofibrate	25	suppressed
Latanoprost	Latanoprost	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	23	suppressed
Colchicine	Colchicine	23	13
Amoxicillin	Amoxicillin	21	17
Nitroglycerin	Nitroglycerin	21	suppressed
Spiriva Respimat	Tiotropium Bromide	21	suppressed
Clobetasol Propionate	Clobetasol Propionate	20	suppressed
Clonazepam	Clonazepam	20	suppressed
Midodrine Hcl	Midodrine Hcl	19	suppressed
Temazepam	Temazepam	19	suppressed
Metronidazole	Metronidazole	18	11
Testosterone	Testosterone	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Eliquis	Apixaban	17	suppressed
Metoprolol Succinate	Metoprolol Succinate	17	suppressed
Risperidone	Risperidone	17	suppressed
Terbinafine Hcl	Terbinafine Hcl	17	13
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	17	suppressed
Citalopram Hbr	Citalopram Hydrobromide	16	suppressed
Divalproex Sodium	Divalproex Sodium	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	15	15
Hydrocortisone	Hydrocortisone	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	14	suppressed
Bupropion Hcl	Bupropion Hcl	14	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Fluticasone Propionate	Fluticasone Propionate	14	suppressed
Montelukast Sodium	Montelukast Sodium	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	14
Epinephrine	Epinephrine	13	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Diazepam	Diazepam	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	12	suppressed
Naltrexone Hcl	Naltrexone Hcl	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Erythromycin	Erythromycin Base	11	11
Ezetimibe	Ezetimibe	11	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error